4//SEC Filing
Byam Rebecca 4
Accession 0001209191-23-033173
CIK 0001828673other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:33 PM ET
Size
6.8 KB
Accession
0001209191-23-033173
Insider Transaction Report
Form 4
Byam Rebecca
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-05-26$1.66/sh+20,000$33,196→ 460,188 total - Purchase
Common Stock
2023-05-25$1.62/sh+20,000$32,348→ 440,188 total
Footnotes (2)
- [F1]The range of prices for the shares of Common Stock is from $1.57 to $1.69. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
- [F2]The range of prices for the shares of Common Stock is from $1.61 to $1.81. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866256
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:33 PM ET
- Size
- 6.8 KB